INVO BioScience, Inc. (INVO) Financial Statements (2024 and earlier)

Company Profile

Business Address 5582 BROADCAST COURT
SARASOTA, FL 34240
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments905,68510,0981,23921226
Cash and cash equivalents905,68510,0981,23921226
Receivables775022822687
Inventory, net of allowances, customer advances and progress billings2642882651014459
Inventory2642882651014459
Prepaid expense     24963
Other undisclosed current assets190283158196  
Total current assets:6216,30610,5431,543731234
Noncurrent Assets
Operating lease, right-of-use asset1,8082,037  
Property, plant and equipment437501132933416
Long-term investments and receivables1,2381,490    
Long-term investments1,2381,490    
Intangible assets, net (including goodwill) 132    
Goodwill      
Intangible assets, net (excluding goodwill) 132    
Other noncurrent assets   2731591216
Total noncurrent assets:3,4834,1614052524632
TOTAL ASSETS:4,10410,46610,9471,795777266
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,3494438577653,0874,916
Taxes payable 11  
Employee-related liabilities5825273932,5153,955
Accounts payable   329372572961
Accrued liabilities946     
Other undisclosed accounts payable and accrued liabilities403(138)    
Deferred revenue1206714714
Debt 100 15821132 
Due to related parties663 65 9211
Contract with customer, liability19
Other liabilities      
Other undisclosed current liabilities1,178804494 255 
Total current liabilities:3,4091,2532,2881,5013,5025,127
Noncurrent Liabilities
Long-term debt and lease obligation 1,90259407 132
Long-term debt, excluding current maturities   326 132
Liabilities, other than long-term debt1,67212,8583,600  
Deferred revenue   2,8573,571
Deferred income tax liabilities210 
Due to related parties   29  
Operating lease, liability1,6701,9025981
Business combination, contingent consideration, liability      
Other undisclosed noncurrent liabilities    0  
Total noncurrent liabilities:1,6721,9032,9164,008 132
Total liabilities:5,0813,1565,2045,5093,5025,259
Equity
Equity, attributable to parent(978)7,3115,743(3,714)(2,724)(4,992)
Common stock111161514
Additional paid in capital48,80546,20137,97820,16018,98213,639
Accumulated deficit(49,784)(38,891)(32,236)(23,889)(21,721)(18,645)
Total equity:(978)7,3115,743(3,714)(2,724)(4,992)
TOTAL LIABILITIES AND EQUITY:4,10410,46610,9471,795777266

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues8224,1601,0371,480494282
Cost of revenue(332)(145)(89)(140)(90)(52)
Cost of goods and services sold(287)(126)(79)  (52)
Gross profit:4914,0159491,341404230
Operating expenses(11,117)(9,232)(6,463)(3,129)(3,038)(871)
Operating loss:(10,626)(5,217)(5,515)(1,788)(2,634)(640)
Nonoperating expense(263)(1,434)(2,832)(379)(442)(62)
Debt instrument, convertible, beneficial conversion feature     895 
Other nonoperating expense      (62)
Interest and debt expense(59)159(2,837)(94)(442)(41)
Other undisclosed income from continuing operations before equity method investments, income taxes   2,8379444241
Loss from continuing operations before equity method investments, income taxes:(10,949)(6,491)(8,347)(2,167)(3,076)(702)
Other undisclosed income (loss) from continuing operations before income taxes59(159)    
Loss from continuing operations before income taxes:(10,890)(6,650)(8,347)(2,167)(3,076)(702)
Income tax expense(3)(5)(0)(0) (1,680)
Loss from continuing operations:(10,893)(6,655)(8,347)(2,168)(3,076)(2,382)
Loss before gain (loss) on sale of properties:(6,655)(8,347)(2,168)(3,076)(2,382)
Other undisclosed net income      
Net loss:(10,893)(6,655)(8,347)(2,168)(3,076)(2,382)
Other undisclosed net income attributable to parent      1,680
Net loss available to common stockholders, diluted:(10,893)(6,655)(8,347)(2,168)(3,076)(702)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,893)(6,655)(8,347)(2,168)(3,076)(2,382)
Comprehensive loss, net of tax, attributable to parent:(10,893)(6,655)(8,347)(2,168)(3,076)(2,382)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: